Published in

Oxford University Press, The Oncologist, 11(19), p. 1115-1117, 2014

DOI: 10.1634/theoncologist.2014-0304

Links

Tools

Export citation

Search in Google Scholar

Drug Development for Hepatocellular Carcinoma: Knowing the Past Helps to Understand the Future

Journal article published in 2014 by Stephen L. Chan ORCID
This paper is made freely available by the publisher.
This paper is made freely available by the publisher.

Full text: Download

Green circle
Preprint: archiving allowed
Upload
Green circle
Postprint: archiving allowed
Upload
Green circle
Published version: archiving allowed
Upload
Policy details
Data provided by SHERPA/RoMEO

Abstract

Hepatocellular carcinoma (HCC) is a highly complicated disease characterized by comorbid cirrhosis and disease heterogeneity. Given multiple failures in the past, we need to learn from previous experiences and generate novel ideas to increase the chance of success. More effort and patience should be exercised in the selection of a homogeneous patient population and identification of predictive markers during drug development for HCC.